Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Other Accumulated Expenses (2016 - 2024)

Utah Medical Products (UTMD) has 8 years of Other Accumulated Expenses data on record, last reported at $111000.0 in Q4 2024.

  • For Q4 2024, Other Accumulated Expenses fell 94.62% year-over-year to $111000.0; the TTM value through Dec 2024 reached $111000.0, down 94.62%, while the annual FY2024 figure was $111000.0, 94.62% down from the prior year.
  • Other Accumulated Expenses reached $111000.0 in Q4 2024 per UTMD's latest filing, down from $2.1 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $2.9 million in Q4 2022 and bottomed at $96000.0 in Q4 2021.
  • Average Other Accumulated Expenses over 5 years is $1.1 million, with a median of $113000.0 recorded in 2020.
  • Peak YoY movement for Other Accumulated Expenses: skyrocketed 2903.12% in 2022, then tumbled 94.62% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $113000.0 in 2020, then dropped by 15.04% to $96000.0 in 2021, then surged by 2903.12% to $2.9 million in 2022, then dropped by 28.44% to $2.1 million in 2023, then crashed by 94.62% to $111000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $111000.0 in Q4 2024, $2.1 million in Q4 2023, and $2.9 million in Q4 2022.